These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1750596)

  • 61. Malignant hyperthermia during a laparoscopic operation.
    Watari A; Kobori H; Yamamoto T
    J Minim Invasive Gynecol; 2011; 18(6):809-11. PubMed ID: 22024269
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Advances in the diagnosis and treatment of malignant hyperthermia.
    Aldrete JA
    Acta Anaesthesiol Scand; 1981 Dec; 25(6):477-83. PubMed ID: 7347075
    [No Abstract]   [Full Text] [Related]  

  • 63. Malignant hyperthermia.
    Byrd JP
    South Med J; 1983 Jul; 76(7):890-3. PubMed ID: 6346509
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dantrolene--a review of its pharmacology, therapeutic use and new developments.
    Krause T; Gerbershagen MU; Fiege M; Weisshorn R; Wappler F
    Anaesthesia; 2004 Apr; 59(4):364-73. PubMed ID: 15023108
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Malignant hyperthermia].
    Chastonay P; Bracco D; Freymond D; Ravussin P
    Rev Med Suisse Romande; 1999 Mar; 119(3):191-202. PubMed ID: 10218414
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Do we foresee new emerging drugs to treat malignant hyperthermia?
    Just KS; Gerbershagen MU; Grensemann J; Wappler F
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):161-4. PubMed ID: 25736705
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Malignant hyperthermia.
    Nissen RL; Yonkers AJ
    Laryngoscope; 1982 Oct; 92(10 Pt 1):1183-6. PubMed ID: 6290807
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dantrolene plasma and urine concentrations after oral pretreatment for malignant hyperthermia: report of a case.
    Wuis EW; Driessen JJ; Evers J; Vree TB; van der Kleyn E
    Eur J Anaesthesiol; 1986 May; 3(3):219-23. PubMed ID: 3780690
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Present-day views on the diagnosis of intraoperative malignant hyperthermia syndrome].
    Mayzner-Zawadzka E; Krawczyńska-Wichrzycka R; Kwiatkowski H; Kamiński B
    Pol Tyg Lek; 1977 Oct; 32(43):1683-6. PubMed ID: 917912
    [No Abstract]   [Full Text] [Related]  

  • 70. [Malignant hyperthermia during emergency craniotomy: a case report].
    Shigematsu K; Shono S; Tanigawa K; Mukaida K; Katori K; Hamada T; Higa K
    Masui; 2003 Jul; 52(7):773-6. PubMed ID: 12910983
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Clinical and morphological findings in a case of malignant hyperthermia (author's transl)].
    Faber P; Gullotta F; Koenen FW
    Dtsch Med Wochenschr; 1975 Sep; 100(39):1974-6. PubMed ID: 1157706
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Malignant hyperthermia. A review and case report.
    Haber J; Hammer DJ; Butler B
    J Am Podiatry Assoc; 1983 Aug; 73(8):422-6. PubMed ID: 6619495
    [No Abstract]   [Full Text] [Related]  

  • 73. Suspected malignant hyperthermia reactions in New Zealand.
    Pollock AN; Langton EE; Couchman K; Stowell KM; Waddington M
    Anaesth Intensive Care; 2002 Aug; 30(4):453-61. PubMed ID: 12180584
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Intraoperative malignant hyperthermia: apropos of a case].
    Madi-Jebara S; Yazbeck P; Bou-Khalil M; Cherfane A; Antakly MC
    J Med Liban; 1997; 45(1):36-9. PubMed ID: 9453994
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Readiness for malignant hyperthermia can be survey stumbling block.
    Traynor K
    Am J Health Syst Pharm; 2016 Jun; 73(12):852-3. PubMed ID: 27261225
    [No Abstract]   [Full Text] [Related]  

  • 76. Clinical variability of possible malignant hyperthermia as revealed by two cases.
    Bendixen D; Poulsen TD; Knudsen F; Nielsen J; Ording H
    Acta Anaesthesiol Belg; 1994; 45(3):93-8. PubMed ID: 7847043
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Malignant hyperthermia: current perspectives.
    Felice-Johnson J; Sudds T; Bennett G
    Am J Hosp Pharm; 1981 May; 38(5):646-51. PubMed ID: 7282692
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Spinal block, after dantrolene pretreatment, for resection of a thigh muscle herniation in a young malignant hyperthermia susceptible man.
    Oikkonen M; Rosenberg PH; Björkenheim JM; Paetau A; Huopaniemi T
    Acta Anaesthesiol Scand; 1987 May; 31(4):309-11. PubMed ID: 3591254
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rationale for dantrolene vs. procainamide for treatment of malignant hyperthermia.
    Nelson TE; Flewellen EH
    Anesthesiology; 1979 Feb; 50(2):118-22. PubMed ID: 434484
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
    Ward A; Chaffman MO; Sorkin EM
    Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.